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Stratum-Specific Expression of Human Transferrin
Receptor Increases Iron in Mouse Epidermis
Leonard M. Milstone1, Brian D. Adams1, Jing Zhou1, Victoria L. Bruegel Sanchez1 and Joshua Shofner1
Epidermal desquamation accounts for 20% of the body’s iron loss each day. Yet, little is known about how iron
content in epidermis is regulated. To test the importance of the transferrin receptor in regulating iron content in
epidermis, we created transgenic mice that have stratum-specific expression of the human transferrin receptor.
The keratin 14 promoter targeted the receptor primarily to basal, proliferating keratinocytes; the involucrin (Inv)
promoter targeted the receptor to suprabasal, differentiating keratinocytes. There were age- and site-dependent
differences in iron content in the epidermis and hair. In both types of transgenic mice, epidermal iron content
increased with age and at 8 weeks was 2–3-fold greater in transgenic mice compared to littermate controls. Iron
was increased up to 2-fold in hair of keratin 14-human transferrin receptor (hTfR) transgenics and 30% in Inv-hTfR
transgenics. No gross or histological changes were seen in transgenic animals with increased iron in the
epidermis. Ferritin expression, which was low in normal epidermis, was greatly increased in both transgenic lines,
indicating that it is the likely depot for the extra iron in these animals. These data show that control of transferrin
receptor expression is sufficient to regulate iron content in proliferating or differentiating keratinocytes in the
epidermis.
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INTRODUCTION
Iron normally does not accumulate in the body, even though
there is limited capacity to rid the body of excess iron. The
20–25% of absorbed iron that is lost through skin is elimi-
nated through desquamation of keratinocytes (Weintraub
et al., 1965; Jacob et al., 1981); very little iron is lost through
sweat (Brune et al., 1986). We have proposed that if a
systemic toxin could be made to accumulate in the
epidermis, then epidermal desquamation might be harnessed
to reduce the body burden of that toxin. We have chosen iron
as a model toxin. One way to test the hypothesis is to create
transgenic mice that accumulate iron in the epidermis so that
they could be bred to mice with hereditary hemochromatosis.
Transferrin receptor endocytosis is the major pathway for
iron uptake into cultured cells (Klausner et al., 1993; Hentze
and Kuhn, 1996). Intracellular iron regulates surface expres-
sion of the transferrin receptor through post-transcriptional
mechanisms (Owen and Kuhn, 1987) and through endosomal
recycling (Callus et al., 1996). Transferrin receptor expression
is reduced on differentiated cells in tissue sections from a
variety of organs (Gatter et al., 1983), and its synthesis is
reduced by transcriptional regulation following experimental
induction of differentiation in hematopoietic cells (Ho et al.,
1986). In cells transfected with transferrin receptor cDNA,
there is a correlation between transferrin receptor expression
and iron uptake (Callus et al., 1996; Luttropp et al., 1998).
Expression of the transferrin receptor is limited to the basal
layer of the epidermis (Gatter et al., 1983). Its absence on
differentiated cells and on stem cells (Tani et al., 2000)
suggests that the transferrin receptor is an important
determinant of the amount and location of iron in the
epidermis.
We report here the production and analysis of transgenic
mice that express the human transferrin receptor in a stratum-
specific manner in the epidermis and in sufficient amount to
overcome homeostatic signals that control iron stores in the
epidermis.
RESULTS
Analysis of K14-hTfR transgenic mice
Two independent lines of mice were established using the
keratin 14 (K14)-human transferrin receptor (hTfR) construct
(Figure 1a), after demonstrating that it could direct synthesis
of the human transferrin receptor in transfected murine
keratinocytes (Supplementary Figure 1a). Each line had litters
with the expected number of males and females, and the
expected number of transgenic and wild-type littermates.
Both lines have been bred for at least six generations; both
demonstrate quantitatively and qualitatively similar expres-
sion of hTfR and effects on epidermal iron. Descriptions will
therefore be limited to line A.
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Expression of the human transferrin receptor was highest
in the basal layer of the epidermis and the outer root sheath of
the hair follicle (Figure 1b); expression showed localized
extension into the spinous layer of the epidermis. Human
transferrin receptor was undetectable in the epidermis of
wild-type littermates (Figures S1d). Newly synthesized hTfR
was identified in cultured keratinocytes from transgenic but
not wild-type mice (Figures S1b). Reverse transcriptase-PCR
revealed the expected amplicon in the RNA from transgenic
but not wild-type epidermis (Figures S1e).
There were no gross phenotypic or histological differences
between skin from transgenic and wild-type littermates. In
particular, there were no differences in thickness, organiza-
tion, or differentiation of the epidermis in specimens
harvested from different anatomic locations of animals up
to 40 weeks of age (data not shown).
Epidermal iron content was considerably greater in the
K14-hTfR transgenic mice than in wild-type littermates
(Figure 1d). Relative differences in epidermal iron between
transgenic and control mice were dependent on age and
anatomic location. Iron content in tail epidermis was
generally lower than iron content in epidermis from other
locations in both transgenic mice and controls. Epidermal
iron content in the K14-hTfR transgenic mice increased at
most body sites between 4 and 20 weeks of age. By contrast,
epidermal iron content in wild-type littermates remained the
same or decreased slightly. As a result, iron content in the
dorsal epidermis of K14-hTfR transgenics was 1.7-fold greater
than in controls at 4 weeks, but 3.3-fold greater than controls
at 20 weeks. Iron content in hair of the K14-hTfR transgenic
mice was as much as 2-fold greater than that in controls at all
times and both locations sampled (dorsal and ventral hair).
Iron content of the liver was equal in transgenic and wild-
type littermates, was greater in females than males, and
slowly increased over time in the females (data not shown).
Total ferritin, ferritin heavy chain, and ferritin light chain
were greatly increased in epidermal extracts from K14-hTfR
transgenic mice compared to wild-type littermates (Figure 1c).
Analysis Inv-hTfR transgenic mice
Two independent lines of mice were established using the
involucrin (Inv)-hTfR construct (Figure 2a), after demonstrat-
ing that it could direct synthesis of the human transferrin
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Figure 1. Basal layer expression of human transferrin receptor in K14-hTfR
transgenic mice increases iron in epidermis. (a) The transgene consists of the
human transferrin receptor coding sequence (hTfRcDNA) in an expression
cassette that contains a human keratin promoter (hK14 P), a b-globin Intron
(b-Int), and human K14 polyA (K14pA). (b) Immunohistochemistry of tail skin
using antibody that reacts with human transferrin receptor but not normal
mouse epidermis (see Figure S1d). (c) Western blots of epidermal extracts
from K14-hTfR transgenic (þ ) or control littermates () were probed (left
panel) for total ferritin (ft) and reprobed for actin (act) or were probed (right
panel) for heavy (Hft) and light (Lft) chains of ferritin using spleen (Sp) as
control. (d) Iron in the epidermis and hair of K14-hTfR transgenic mice. Iron
was measured in epidermis from various locations and in hair. Each point is
the mean7SD from eight to 13 animals. Iron content in samples from
transgenic mice (E) was significantly greater (at least Pp0.008) than
wild-type littermates (&) at all locations and at all times.
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Figure 2. Suprabasal expression of human transferrin receptor in Inv-hTfR
transgenic mice increases iron in the epidermis. (a) The transgene consists of
the human transferrin receptor coding sequence (hTfRcDNA) in an expression
cassette that contains a human involucrin promoter/intron (hInv P/I), and an
SV40 polyA (SVpA). (b) Immunohistochemistry of tail skin using antibody that
reacts with hTfR but not normal mouse epidermis (see Figures S2d).
(c) Western blots of epidermal extracts from Inv-hTfR transgenic (þ ) or
control littermates () were probed (left panel) for ferritin (ft) and reprobed for
actin (act) or were probed (right panel) for heavy (Hft) and light (Lft) chains of
ferritin using spleen (Sp) as control. (d) Iron in the epidermis and hair
of Inv-hTfR transgenic mice. Iron was measured in the epidermis from
various locations and in hair. Each point is the mean7SD from six to 10
animals. Iron content in samples from transgenic mice (E) was significantly
greater (at least Pp0.04) than wild-type littermates (&) at all locations and
at all times.
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receptor in transfected murine keratinocytes (Figure S2a).
Each line had litters with the expected number of males and
females, and the expected number of transgenic and wild-
type littermates. Both lines have been bred for at least six
generations; both demonstrate quantitatively and qualita-
tively similar expression of hTfR and effects on epidermal
iron. Line B bred poorly, so descriptions will be limited to
line A.
Expression of the human transferrin receptor was highest
in suprabasal cells in the epidermis from the first layer above
the basal layer extending to the stratum corneum (Figure 2b).
There was intense staining of the inner root sheath and in
some matrix cells in the hair follicle. Human transferrin rece-
ptor was undetectable in the epidermis of wild-type litter-
mates (Figure S2d). Newly synthesized hTfR was identified in
cultured keratinocytes from transgenic but not wild-type
mice, and was greatly increased by subjecting the cells to
calcium-induced differentiation (Figure S2b). Reverse trans-
criptase-PCR revealed the expected amplicon in the RNA
from transgenic but not wild-type epidermis (Figure S2e).
There were no gross phenotypic or histological differences
between the transgenic animals and their wild-type litter-
mates. In particular, there were no discernable differences in
thickness, organization, or differentiation of the epidermis in
specimens harvested from different anatomic locations of
animals up to 40 weeks of age (data not shown).
Epidermal iron content was considerably greater in the
Inv-hTfR transgenic mice compared to wild-type littermates
(Figure 2d). Relative differences in epidermal iron between
transgenic and control mice were dependent on age and
anatomic location. Iron content in tail epidermis was
generally lower than iron content in the epidermis from
other locations in both transgenic mice and controls.
Epidermal iron content in the Inv-hTfR transgenic mice
increased at most body sites between 4 and 20 weeks of age.
By contrast, epidermal iron content in wild-type littermates
remained the same. As a result, iron content in the dorsal
epidermis of transgenics was 1.9-fold greater than in controls
at 4 weeks, but 2.9-fold greater than controls at 20 weeks.
Iron content in hair of the Inv-hTfR transgenic mice was as
much as 50% greater than that in controls at all times and
from both locations sampled (dorsal and ventral hair). Iron
content of liver was the same in transgenic animals and wild-
type littermates (data not shown).
Total ferritin, ferritin heavy chain, and ferritin light chain
were greatly increased in epidermal extracts from Inv-hTfR
transgenic mice compared to wild-type littermates (Figure 2c).
DISCUSSION
Control of transferrin receptor expression is sufficient to
regulate iron content in vivo, as shown by our analysis of
transgenic mice that express human transferrin receptor 1 in
the epidermis. This result was not a foregone conclusion:
there have been no previous reports of transferrin recep-
tor transgenic mice and there is increasing recognition that
iron homeostasis involves multiple pathways for iron
uptake, secretion, and hormonal regulation (Hentze et al.,
2004).
The finding of increased iron in the epidermis of mice with
stratum-specific expression of the transgene has several
implications. Proteins needed for appropriate transferrin
receptor trafficking or endosome recycling must be present
in sufficient excess to allow increased iron uptake and
storage. Moreover, proteins that traffic with transferrin
receptor apparently are not coordinately downregulated by
increased intracellular iron nor by the differentiation program
that normally would downregulate transferrin receptor
expression.
Epidermal iron has been measured in several diseases, and
our results have implications for the interpretation of those
data. As transferrin receptor-mediated transport of iron into
keratinocytes appears to be a critical determinant of iron
content in keratinocytes and as transferrin receptor expres-
sion normally is restricted to proliferating basal keratinocytes,
any condition that increases the proportion of proliferating
keratinocytes in the epidermis should be expected to increase
iron content in the epidermis. Psoriasis and, to a lesser
degree, dermatitis are two diseases in which the epidermis is
hyperproliferative and may show evidence of proliferating,
suprabasal keratinocytes. Data demonstrating increased iron
in the epidermis in psoriasis and dermatitis (Forslind et al.,
1999) may be a direct consequence of a change in the
proportion of proliferating to differentiating cells, rather than
an indication that iron has a role in the pathogenesis of those
diseases.
Elevated ferritin in the epidermis of transgenic animals
indicates that the epidermal response to increased intracel-
lular iron is physiologically appropriate, even if the (trans-
genic) cause of its increase is not. In human skin, ferritin
normally is detected only in the basal cell layer, but is
increased and readily identified in all epidermal layers in
response to UV light (Applegate et al., 1998; Seite et al.,
2004). The increased ferritin in the K14-hTfR and Inv-hTfR
transgenic animals proves that both proliferating and
differentiating keratinocytes are capable of responding to an
iron load by accumulating ferritin. The increase in both
subunits of ferritin in the transgenic epidermis is consistent
with current understanding that the H-chain is necessary to
oxidize newly absorbed iron and that the L-chain is increased
in tissues that store iron (Harrison and Arosio, 1996).
Iron-overloaded animals have increased susceptibility to
inflammatory (Reelfs et al., 2004) and neoplastic skin disease
(Bhasin et al., 2003). The K14-hTfR and Inv-hTfR transgenic
mice that accumulate iron in the epidermis should be useful
in distinguishing the effects of local from systemic iron
overload. These animals should also be a useful tool in
further defining the role of epidermal desquamation in iron
homeostasis.
MATERIALS AND METHODS
Animals
The K14-hTfR mice were derived by the Yale Animal Research Core
transgenic facility (Yale University School of Medicine, New Haven,
CT) in C57Bl/6J SJL/J mice. From 24 pups, six were positive for the
transgene by dot blot. Inv-hTfR mice were derived by the Yale
Immunobiology mouse transgenic facility in C57Bl/6J mice. From
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100 pups, 25 were positive for the transgene by dot blot. All mouse
production and experimentation was performed in compliance with
guidelines of the Yale Institutional Animal Care and Use Committee.
All animals reported here were fed standard mouse chow containing
0.226 g/kg iron (TD2018; Harlan Teklad, Madison, WI) and have
been backcrossed into C57Bl/6J for at least six generations.
Transgenic and non-transgenic littermates were housed together,
but separated by sex.
Cells
The epidermis is separated from the dermis by overnight exposure to
Dispase II (165–859; Roche, Indianapolis, IN) at 41C (Kitano and
Okada, 1983), and a single-cell suspension of keratinocytes obtained
by brief exposure to trypsin:EDTA. Human foreskin keratinocytes
were grown in low-calcium, serum-free medium (Zhou et al., 1999).
Murine BALB/c keratinocytes and keratinocytes isolated from
transgenic pups were grown in low-calcium, serum-containing
medium (Bruegel Sanchez et al., 2004).
Transgene construction
Human transferrin receptor 1 cDNA (pCDTR-1; ATCC, Manassas,
VA), free of 30and 50 regulatory elements (hereafter called hTfR)
(Luttropp et al., 1998), was inserted into the Inv promoter cassette
provided by Lorne Taichman (Carroll et al., 1993) or into a K14
promoter cassette provided by Elaine Fuchs (Hutton et al., 1998).
Genomic dot blots
Genomic DNA, spotted on Hybond-Nþ (RPN203B; Amersham,
Piscataway, NJ), was probed using a 32P-labeled, 800 bp, Xba/HindIII
fragment from the human transferrin cDNA that does not hybridize to
murine DNA.
PCR
The hTfR transgene was detected by 30 cycles of PCR on genomic
DNA, using Taq polymerase (M1661, Promega) and primers for the
hTfR coding sequence that do not amplify murine DNA. Reverse
transcriptase-PCR for hTfR in cellular RNA (TRIzol, Invitrogen,
Carlsbad, CA) used the same primers and primers for glyceralde-
hyde-3-phosphate dehydrogenase (details in Figures S1 and S2).
Human transferrin receptor synthesis
Keratinocytes from transgenic pups or BALB/c keratinocytes trans-
fected with K14-hTfR and INV-hTfR transgenes using Lipofectamine
(Invitrogen, Carlsbad, CA) were labeled with Tran35S-Label
(370 MBq/ml; ICN, Aurora, OH). Six hours later, cells were extracted
in TENP (50 mM Tris, pH 8.0, 5 mM EDTA, 1% NP-40, 0.15 M NaCl,
and protease inhibitors). Protein (500 mg) was incubated with 1 mg of
antibody B3/25 (Omary et al., 1980), specific for human TfR (Roche,
Indianapolis, IN) and protein A beads (Amersham, Piscataway, NJ)
overnight at 41C. After washing three times with TENP containing
0.4 M NaCl, the eluted receptor was resolved by 10% SDS-PAGE and
detected by autoradiography.
Histology and immunohistochemistry
Tissues were fixed in Bouin’s solution, embedded in paraffin,
sectioned at 5mm, deparaffinized and stained with hematoxylin and
eosin or an anti-human transferrin receptor antibody (MS-1096-S1;
NeoMarkers, Freemont, CA) and a silver-enhanced secondary
antibody (RPN471; Amersham).
Iron measurement
Plucked hair and dispase-separated epidermis from 1 2 cm pieces
of skin were rinsed in PBS, blotted, and then dried overnight at 651C.
Non-heme iron was measured using a dye binding assay (Torrance
and Bothwell, 1980), adapted to a microtiter plate format (Adams BD
et al. J Invest Dermatol (in press)). Data for the epidermis and hair
were pooled from males and females, as there was no sex difference
when analyzed separately. Liver data were separated by sex.
Ferritin measurement
Epidermal sheets were extracted by sonication on ice in 10 mM Tris,
pH 7.4. containing 1% SDS and 1 mM dithiothreitol and protease
inhibitors. Protein was measured by a modification of the Bramhall
assay (Milstone et al., 1982), and 20 mg separated by 15% SDS-
PAGE. After protein transfer for 3.5 hours at 100 mA, the 21 kDa
ferritin band was identified using a rabbit, anti-horse ferritin antibody
at 1:1,750 (F-5762; Sigma, St Louis, MO), a goat anti-rabbit
horseradish peroxidase-antibody at 1:5,000 (NA934; Amersham),
and an ECL kit (RPN2106; Amersham) and X-ray film (870–1302;
Kodak, Rochester, NY). Protein loading was monitored by stripping
and reprobing the blot using a rabbit anti-mouse actin antibody at
1:2,000 (A-2066; Sigma). For the estimation of H- and L-chain of
ferritin, epidermis was extracted with 20 mM Tris, pH 7.4 plus
protease inhibitors and then 20 mg separated on non-denaturing, 7%
polyacrylamide gels run for 3 hours at 100 V (Santambrogio et al.,
2000). Protein was transferred to polyvinylidene difluoride mem-
brane (162–0176; Biorad, Hercules, CA) for 4 hours at 215 mA. The
H- and L-chain-specific rabbit, anti-ferritin antibodies, a kind gift
from Paolo Santambrogio (Scientific Institute of Recovery and Care,
Milan, Italy) were used at 1:2,000.
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SUPPLEMENTARY MATERIAL
Figure S1. (a) Transgene expression in transfected mouse keratinocytes.
Cultured cells were labeled with 35S. Extracted protein was immunoprecipi-
tated with antibody B3/25 and human transferrin receptor identified on SDS-
PAGE by autoradiography. HK – positive control of human keratinocytes. MK
– negative control of BALB/c keratinocytes. MKþK14hTFR – BALB/c
keratinocytes transfected with the hTfR construct and labeled 72 hours later.
(b) Synthesis of human transferrin receptor in keratinocytes isolated from K14-
hTfR transgenic mice. Cell lines were established from six littermates, labeled
with 35S, and analyzed for human transferrin receptor synthesis as in (a). PCR
of genomic DNA using primers specific for the human transferrin receptor
distinguished transgenic (pcrþ ) from wild-type (pcr) littermates. The
labeled band at approximately 92 kDa, the expected size of the human
transferrin receptor (hTfR), was seen in only the pcrþ cells. A non-specifically
precipitating protein was seen in all lanes, and serves as an internal loading
control. (c and d) Expression of hTfR is limited to lower layers of epidermis in
transgenic mice. Immunohistochemistry, using Neomarker antibody to
human transferrin receptor, was done on tail skin from a K14-hTfR transgenic
mouse. Expression is most intense in the basal layer of the epidermis and
sebaceous glands and the outer root sheath of hair follicles of transgenic
animals (c), but is absent from the upper layers of epidermis and totally absent
www.jidonline.org 651
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from skin of non-transgenic littermates (d). (e) mRNA for the hTfR transgene is
found in the epidermis only in K14-hTfR transgenic mice. Reverse
transcriptase-PCR was performed on RNA extracted from epidermis and liver
of littermates. The 18 0bp pcr-amplified cDNA product was identified in
epidermis of two animals that were positive for the transgene in genomic
DNA (þ ) and absent from two animals that were negative for the transgene in
genomic DNA (). RNA from liver (L), which should not express protein from
a K14 promoter, did not yield amplified product. In separate reactions, the
525 bp band, using primers for glyceraldehyde-3-phosphate dehydrogenase,
verified the presence of amplifiable cDNA. Positive pcr control¼ genomic
DNA(D); negative pcr control (C)¼water.
hTfR1: 50-CTGCTATGGGACTATTGCTGTG-30.
hTfR2: 50-CCGACAACTTTCTCTTCAGGTC-30.
GAPDH1: 50CTCCTTGGAGGCCATGTAGGCCATG.
GAPDH2: 50GCAACTGCTTAGGGGGGGTGGCCAG.
Figure S2. (a) Transgene expression in transfected mouse keratinocytes.
Cultured cells were labeled with 35S. Extracted protein was immunoprecipi-
tated with antibody B3/25 and human transferrin receptor identified on SDS-
PAGE by autoradiography. HK – positive control of human keratinocytes. MK
– negative control of BALB/c keratinocytes. MKþ Inv-hTFR – BALB/c
keratinocytes transfected with the hTfR construct and labeled 72 hours later.
(b) Synthesis of human transferrin receptor in keratinocytes isolated from Inv-
hTfR transgenic mice is regulated by calcium. Cell lines were established from
two transgenic animals, cultured for 2 days in either low calcium (lo) or high
calcium (hi), labeled with 35S and analyzed for human transferrin receptor
synthesis (hTfR) as in (a). The labeled band at approximately 92 kDa, the
expected size of the human transferrin receptor, was faint in cells grown in
low calcium but strong in cells grown in high calcium. (c and d) Expression of
hTfR is limited to the upper layers of the epidermis in transgenic mice.
Immunohistochemistry, using Neomarker antibody to human transferrin
receptor, was done on sections of tail skin from an Inv-hTfR transgenic
mouse. In transgenic animals (c), expression is most intense above the basal
layer of the epidermis and the inner root sheath of hairs follicles. Staining was
absent from sebaceous glands and the outer root sheath of hair follicles and
totally absent from skin of non-transgenic littermates (d). (e) mRNA for the
hTfR transgene is found in the epidermis only in Inv-hTfR transgenic mice.
Reverse transcriptase-PCR was performed on RNA extracted from the
epidermis and liver of littermates. The 180 bp pcr-amplified cDNA product
was identified in the epidermis of two animals that were positive for the
transgene in genomic DNA (þ ) and absent from two animals that were
negative for the transgene in genomic DNA (). RNA from liver (L), which
should not express protein from an Inv promoter, did not yield amplified
product. In separate reactions, the 525 bp band, using primers for
glyceraldehyde-3-phosphate dehydrogenase, verified the presence of amplifi-
able cDNA. Positive pcr control¼ genomic DNA(D); (see Figure Supplemen-
tary 1e for primers used).
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